Atlas Trials

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Clinical trial NCT04491877 · COMPLETED

Trial details

NCT number
NCT04491877
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infection
Start date
2020-09-17
Primary completion
2023-04-13
Enrollment
259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.